Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia

A.A.J.M. van de Ven, J.W. Douma, C.M.A. Rademaker, A.M. van Loon, A.M.J. Wensing, J.J. Boelens, E.A.M. Sanders, J.M. van Montfrans

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A 14 year old common variable immunodeficiency patient developed severe protein-losing enteropathy. A chronic enteral infection with human parechovirus type 1 and norovirus was diagnosed. Treatment strategies aimed at virus eradication and providing supportive care were ineffective. The antipicornavirus agent pleconaril did not have any effect on viral replication. Symptoms improved on immunosuppressive therapy, suggesting infection-related immune dysregulation in an immuno-compromised host.

Original languageEnglish
Pages (from-to)611-614
Number of pages4
JournalAntiviral Therapy
Volume16
Issue number4
DOIs
Publication statusPublished - 2011

Keywords

  • ORAL PLECONARIL
  • INFECTIONS
  • EFFICACY
  • TRIALS
  • ADULTS

Fingerprint

Dive into the research topics of 'Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia'. Together they form a unique fingerprint.

Cite this